IN8bio, Inc (INAB) Provides INB-200 Clinical Update, Outlines 2023 Pipeline Goals

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. AAPL
4. SPGI
5. USO
6. DELL
7. ENOV
8. AON
9. NIO
10. EIX

Go back to IN8bio, Inc (INAB) Provides INB-200 Clinical Update, Outlines 2023 Pipeline Goals
(NASDAQ: INAB) Delayed: 1.09 -0.01 (0.91%)
Previous Close $1.10    52 Week High $ 
Open $1.10    52 Week Low $ 
Day High $1.13    P/E N/A 
Day Low $1.08    EPS $ 
Volume 19,948